Development of MDSC - CD11b tracer for immune PET imaging in glioblastoma model

Conclusions: Imaging TAMs and MDSCs with 89Zr-labeled anti-CD11b Ab targeting was validated in a mouse model of malignant gliomas, demonstrating the feasibility of monitoring immune response during immunotherapy.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Nigam, S., McCarl, L., Edinger, R. S., kumar, R., Anderson, C., Kohanbash, G., Edwards, W. B. Tags: Preclinical Probes for Oncology Posters Source Type: research